Your browser doesn't support javascript.
loading
Adult lifetime body mass index trajectories and endometrial cancer risk.
Dalmartello, Michela; Vermunt, Jeroen; Negri, Eva; Levi, Fabio; La Vecchia, Carlo.
Afiliação
  • Dalmartello M; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Vermunt J; Department of Methodology and Statistics, Tilburg University, Tilburg, The Netherlands.
  • Negri E; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Levi F; Department of Humanities, Università Telematica Pegaso, Naples, Italy.
  • La Vecchia C; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
BJOG ; 129(9): 1521-1529, 2022 08.
Article em En | MEDLINE | ID: mdl-34962692
ABSTRACT

OBJECTIVE:

To identify body mass index (BMI) trajectories in adult life and to examine their association with endometrial cancer (EC) risk, also exploring whether relations differ by hormonal replacement therapy use.

DESIGN:

Pooled analysis of two case-control studies.

SETTING:

Italy and Switzerland. POPULATION A total of 458 EC cases and 782 controls.

METHODS:

We performed a latent class growth model to identify homogeneous BMI trajectories over six decades of age, with a polynomial function of age. Odds ratios (ORs) and the corresponding 95% CI for EC risk were derived through a multiple logistic regression model, correcting for classification error. MAIN OUTCOME

MEASURES:

The relation of BMI trajectories with endometrial cancer.

RESULTS:

We identified five BMI trajectories. Compared with women in the 'Normal weight-stable' trajectory, a reduction by about 50% in the risk of EC emerged for those in the 'Underweight increasing to normal weight' (95% CI 0.28-0.99). The 'Normal weight increasing to overweight' and the 'Overweight-stable' trajectories were associated with, respectively, an excess of 3% (95% CI 0.66-1.60) and of 71% (95% CI 1.12-2.59) in cancer risk. The OR associated to the trajectory 'Overweight increasing to obese' was 2.03 (95% CI 1.31-3.13). Stronger effects emerged among hormonal replacement therapy never users (OR 2.19 for the 'Overweight-stable' trajectory and OR 2.49 for the 'Overweight increasing to obese' trajectory).

CONCLUSIONS:

Our study suggests that longer exposure to overweight and obesity across a lifetime is associated with an increased risk of endometrial cancer. Weight during adulthood also appears to play an important role. TWEETABLE ABSTRACT Longer exposure to overweight and obesity across a lifetime is associated with an increased risk of endometrial cancer.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Sobrepeso Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Sobrepeso Idioma: En Ano de publicação: 2022 Tipo de documento: Article